Skip to main content
All lobbying filings

GLAUKOS CORPORATION

Lobbying for GLAUKOS CORPORATION · Research and product development

 Filing 3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Expenses
$50,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
California

Official filing document

 Bills named in this filing 3
  • HR 3514
    Improving Seniors’ Timely Access to Care Act of 2025
  • S 1816
    Improving Seniors’ Timely Access to Care Act of 2025
  • HR 2527
    Early Detection of Vision Impairments for Children Act of 2025
 Lobbying activity 2
Medicare/Medicaid

H.R. 3514/ S. 1816 Improving Seniors Timely Access to Care Act of 2025 H.R. 2527 Early Detection of Vision Impairments for Children Act of 2025

Medical/Disease Research/Clinical Labs

Legislation regarding FDA regulation of combination products

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem